- Spirometers are essential diagnostic devices used to assess lung function by measuring the volume and flow of air during inhalation and exhalation. They play a crucial role in diagnosing and monitoring respiratory conditions, including COPD, asthma, and lung cancer, supporting better disease management and treatment planning
- The spirometer market is experiencing significant growth, driven by the increasing prevalence of respiratory diseases, advancements in spirometer technology, and the rising demand for early diagnosis. In addition, the growing focus on healthcare infrastructure and the shift toward homecare monitoring are further contributing to the market's expansion
- North America is expected to dominate the spirometer market with a share of 42.1%, due to the high prevalence of chronic respiratory diseases, particularly chronic obstructive pulmonary disease (COPD), asthma, and lung cancer
- Asia-Pacific is expected to be the fastest growing region in the spirometer market during the forecast period due to expanding healthcare investments, rapid urbanization, and an increasing aging population, which contributes to the rising burden of respiratory diseases
- Flow measurement spirometer segment is expected to dominate the market with a market share of 67.2% due to its widespread application in diagnosing and monitoring respiratory conditions, such as asthma and chronic obstructive pulmonary disease (COPD). These devices are favored for their accuracy in measuring airflow, essential for assessing lung function, and are commonly used in both clinical and home settings
